Supreme Pharmaceuticals Inc.
OTCBB : SPRWF
CNSX : SL

Supreme Pharmaceuticals Inc.

September 23, 2014 08:30 ET

Supreme Appoints Chris Bechtel to Advisory Board

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 23, 2014) - Supreme Pharmaceuticals Inc. (the "Company") (OTCBB:SPRWF) (CSE:SL) is pleased to announce the appointment of Chris Bechtel to its advisory board. Mr. Bechtel brings a wealth of experience in capital markets, start-ups, and medicinal marijuana to the Company.

Mr. Bechtel launched a small business in the oil and gas industry in Houston, Texas in 1983 at the age of 23, which he then grew to revenues of over $30 million in six countries. In 2006, Mr. Bechtel sold his business to Weatherford International, one of the largest global providers of oil and gas services. Mr. Bechtel continues to run the original labs business, as well as other divisions for Weatherford, representing a combined staff of 2,500 employees and gross revenues of approximately $500M.

Mr. Bechtel became deeply involved in the marijuana industry after investigating the medical benefits of cannabis for an immediate family member. This led Mr. Bechtel to become a private investor in, and consultant and advisor to, over half-a-dozen companies in the cannabis sector.

"We are thrilled by this addition to our team," said David Stadnyk, President and CEO of Supreme Pharmaceuticals. "Chris has a deep understanding of the cannabis industry, knows how to grow and run a large multinational business, and brings great strategic value to the Company."

Mr. Bechtel stated, "Growing a fledgling startup into a successful international business was one of the most gratifying experiences of my career; Supreme is well on its way to taking the same journey, and I am excited to be able to support that process in an industry that can bring so many benefits to so many people."

Contact Information